MedPath

Effects of Na- selenite in Patients with Coronary Artery Diseases

Phase 3
Conditions
Coronary artery disease.
Atherosclerotic heart disease of native coronary artery with angina pectoris
I25.11
Registration Number
IRCT20110123005670N28
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

Willingness to participate in the study and sign informed consent form after full knowledge of the purpose and method of the study
Men and women with 30-65 years age range
Diagnosis of atherosclerosis by a physician based on angiography results with at least 50% vascular obstruction in at least one vessel
Not using any antioxidant and anti-inflammatory supplements for at least 1 month before starting the study
Patients with overweight and obesity (BMI = 25 - 35 Kg / m²)

Exclusion Criteria

A variety of malignancies, autoimmune and infectious diseases
Chronic diseases such as liver, kidney and thyroid diseases
Pregnancy and lactation
Exposure to any side effects during the study
Consumers of antacids, antibiotics, alcohol and cigarette users
Blood disease and osteoporosis
allergies

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath